26.92
-0.07 (-0.26%)
-0.07 (-0.26%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 153,920 |
|
|||||
| News | - | ||||||
| Day High | 27.31 | Low High |
|||||
| Day Low | 26.4412 | ||||||
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| iTeos Therapeutics Inc | ITOS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| -0.07 | -0.26% | 26.92 | 18:00:13 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 26.99 | 26.4412 | 27.31 | 26.92 | 26.99 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,626 | 153,920 | $ 27.00 | $ 4,156,480 | - | 17.43 - 47.61 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:03:03 | formt | 1,700 | $ 26.92 | USD |
Period:
Draw Mode:
iTeos Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 947.85M | 35.21M | 20.12M | $ - | $ - | -0.49 | -24.90 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | -1.33M | 0.40% |
iTeos Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ITOS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 27.77 | 28.01 | 26.41 | 27.37 | 107,097 | -0.85 | -3.06% |
| 1 Month | 26.91 | 28.07 | 25.41 | 26.97 | 130,070 | 0.01 | 0.04% |
| 3 Months | 24.64 | 29.6734 | 23.755 | 26.74 | 164,833 | 2.28 | 9.25% |
| 6 Months | 24.03 | 29.765 | 17.43 | 24.76 | 326,577 | 2.89 | 12.03% |
| 1 Year | 24.47 | 47.61 | 17.43 | 27.89 | 273,919 | 2.45 | 10.01% |
| 3 Years | 19.70 | 47.61 | 17.43 | 27.64 | 256,863 | 7.22 | 36.65% |
| 5 Years | 19.70 | 47.61 | 17.43 | 27.64 | 256,863 | 7.22 | 36.65% |
iTeos Therapeutics Description
| ITeos Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of immuno-oncology therapeutics for patients. Its product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody. |
